ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 128 filers reported holding ZS PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,000 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 2,576,723 | $134,995,000 | 89.47% |
| DAFNA Capital Management LLC | 67,100 | $3,515,000 | 2.97% |
| Opaleye Management Inc. | 95,000 | $4,977,000 | 1.98% |
| VHCP Management, LLC | 100,000 | $5,239,000 | 1.48% |
| Redmile Group, LLC | 302,988 | $15,874,000 | 1.30% |
| Perceptive Advisors | 361,777 | $18,953,000 | 1.14% |
| SECTORAL ASSET MANAGEMENT INC | 465,839 | $24,405,000 | 1.02% |
| SCOPIA CAPITAL MANAGEMENT LP | 924,804 | $48,450,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 88,943 | $4,660,000 | 0.94% |
| Partner Investment Management, L.P. | 10,059 | $527,000 | 0.74% |